Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.19% | 177.17 | 0.7% | $1337.76m | |
| MRK | Merck & Co., Inc. | -0.07% | 91.11 | 0.7% | $1167.06m | |
| PFE | Pfizer Inc. | -1.70% | 51.54 | 0.9% | $1094.78m | |
| LLY | Eli Lilly & Co. | -1.48% | 319.45 | 1.1% | $1030.26m | |
| BMY | Bristol-Myers Squibb Co. | -1.49% | 75.86 | 1.0% | $992.94m | |
| ABBV | AbbVie, Inc. | -0.97% | 151.67 | 1.9% | $949.40m | |
| AZN | AstraZeneca Plc | -1.47% | 65.10 | 1.0% | $435.00m | |
| SGEN | Seagen Inc. | 0.83% | 178.40 | 5.7% | $318.50m | |
| TPTX | Turning Point Therapeutics, Inc. | -0.12% | 75.16 | 0.0% | $287.74m | |
| GSK | GSK Plc | -0.59% | 43.28 | 0.2% | $274.87m | |
| NVS | Novartis AG | -1.33% | 83.41 | 0.2% | $162.39m | |
| HZNP | Horizon Therapeutics Plc | -0.21% | 79.59 | 5.4% | $161.46m | |
| MRTX | Mirati Therapeutics, Inc. | 3.49% | 69.47 | 1.6% | $151.82m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.27% | 145.32 | 0.0% | $141.94m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.96% | 147.25 | 8.1% | $141.86m |
Company Profile
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which engages in the development of treatments for highly resistant cancers and viruses. Its clinical stage drugs include Annamycin, an Anthracycline being studied for the treatment of relapsed or refractory acute myeloid leukemia (AML), and WP1066, an Immune/Transcription Modulator targeting brain tumors, pancreatic cancer, and AML. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.